Clinical Efficacy, Safety And Tolerability Of BIO-C (micronized Silymarin) As A Galactagogue
Notes for this study:
||Non-randomized controlled trial
|Number of Subjects
In this 63-day trial, 50 women were divided into two groups: BIO-C® supplementation (micronized Silymarin, 420 mg/day) or placebo supplementation. Milk volume was assessed at 30 days and 63 days by weighing the infant before and after breastfeeding sessions and measuring any additional milk obtained via breast-pump after a feeding. At day 30, women treated with BIO-C® produced more milk than women in the placebo group (989.76 g vs. 649.76 g). At day 63, women in the BIO-C® continued to produce more milk compared to placebo (1119.24 g vs. 700.56 g). There was no difference in main milk biochemical characteristics (e.g., proteins, sugars, lipids, water) between the two groups.